Market icon

RFK 将停止对哪些疫苗的推荐?

Market icon

RFK 将停止对哪些疫苗的推荐?

$1,399,277 交易量

Dec 31, 2025
Polymarket

$1,399,277 交易量

Polymarket

脊髓灰质炎

$22,600 交易量

COVID-19

$602,048 交易量

人乳头瘤病毒

$316,492 交易量

流感

$28,349 交易量

乙型肝炎

$166,216 交易量

麻疹、腮腺炎和风疹

$263,573 交易量

This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.

The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
交易量
$1,399,277
结束日期
Dec 31, 2025
创建时间
Feb 21, 2025, 7:10 PM ET
This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution. The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

已提议结果: 否

无争议

最终结果: 否

警惕外部链接哦。

Frequently Asked Questions

"RFK 将停止对哪些疫苗的推荐?" is a prediction market on Polymarket with 6 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "脊髓灰质炎" at 0%, followed by "COVID-19" at 0%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 0¢ implies that the market collectively assigns a 0% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "RFK 将停止对哪些疫苗的推荐?" has generated $1.4 million in total trading volume since the market launched on Feb 22, 2025. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "RFK 将停止对哪些疫苗的推荐?," browse the 6 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

This is a wide-open market. The current leader for "RFK 将停止对哪些疫苗的推荐?" is "脊髓灰质炎" at just 0%, with "COVID-19" close behind at 0%. With no outcome commanding a strong majority, traders see this as highly uncertain, which can present unique trading opportunities. These odds update in real-time, so bookmark this page to watch how the probabilities evolve.

The resolution rules for "RFK 将停止对哪些疫苗的推荐?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.